The Changing Landscape of Post-Mortem Toxicology Worldwide
Across the globe, forensic toxicology laboratories are facing unprecedented challenges. Drug-related deaths continue to rise in many regions, driven not only by traditional drugs of abuse but also by synthetic opioids, novel psychoactive substances (NPS), prescription medication misuse, and increasingly complex poly-drug intoxications.
From North America and Europe to Asia-Pacific and Latin America, medical examiners, coroners, forensic pathologists, and toxicologists are being asked to deliver faster, more comprehensive toxicological investigations while managing growing caseloads and limited laboratory resources.
A Global Public Health Challenge
The nature of drug-related mortality has changed significantly over the past decade.
In the United States and Canada, synthetic opioids such as fentanyl have transformed overdose investigations. Across Europe, toxicologists continue to monitor evolving trends involving designer drugs, synthetic cannabinoids, and prescription medicines. Meanwhile, emerging economies are increasingly encountering challenges associated with new psychoactive substances entering local drug markets.
What unites forensic laboratories worldwide is the need to identify a growing number of substances that may contribute to a death.
Many cases now involve:
- Opioids and synthetic opioids
- Benzodiazepines
- Cocaine and metabolites
- Amphetamine-type stimulants
- Cannabis metabolites
- Prescription medications
- New and emerging psychoactive substances
Rarely does a single substance tell the whole story. Today’s toxicologists are often tasked with understanding the contribution of multiple drugs present simultaneously.
The Complexities of Post-Mortem Specimens
Unlike clinical toxicology, post-mortem testing introduces additional challenges that can significantly impact analytical workflows.
These include:
- Post-mortem redistribution
- Drug degradation after death
- Variable specimen quality
- Matrix effects
- Limited sample availability
Interpretation of Complex Toxicological Findings
As a result, laboratories require screening approaches capable of providing broad and reliable toxicological information early in the investigation process.
Looking Ahead
As the global drug landscape continues to evolve, so too must forensic testing strategies. Comprehensive screening is becoming increasingly important in helping laboratories manage complexity while supporting accurate death investigations.
Ask us about the Evidence MultiSTAT, or visit our website to learn how our multiplex testing technology is helping forensic laboratories meet these growing demands.
Email: info@randoxtoxicology.com.